AL239 Flualprazolam

Description

• 1. Comprehensive Scientific Overview
  AL239 Flualprazolam is a high-purity batch of the potent triazolobenzodiazepine derivative. Flualprazolam. A primary question in contemporary psychopharmacology research is ‘Flualprazolam vs Alprazolam’ – the key distinction lies in the addition of a fluorine atom to the core structure, which significantly alters its pharmacological profile.

  This structural modification, as detailed on various Flualprazolam wiki pages, results in increased potency and a considerably extended Flualprazolam half-life. Researchers study what is Flualprazolam used for in a controlled setting to understand its effects on GABA-A receptor subunits, its metabolic pathway, and its overall impact on the central nervous system.

  Our AL239 product is provided as a pure powder, the active pharmaceutical ingredient (API) form, allowing for precise volumetric dosing in solution-based research, unlike commercially available Flualprazolam pills or Flualprazolam tablets.

  2. Advanced Chemical Specifications & Properties

  • Chemical Name: 8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
  • Synonyms: Flualprazolam API, Flualprazolam Base
  • CAS Number: 28981-97-7
  • Molecular Formula: C₁₇H₁₂ClFN₄
  • Molecular Weight: 326.76 g/mol
  • Appearance: Fine, white to off-white crystalline powder
  • Purity: ≥99% (HPLC-verified)
  • Solubility: Soluble in Propylene Glycol (PG), ethanol, and DMSO for creating a Flualprazolam liquid or Flualprazolam solution
  • Storage: Store in a tight, light-resistant container at controlled room temperature (15–30°C)
  • Stability: 24 months when stored under recommended conditions

  3. Authorized Research Applications
  Our premium AL239 Flualprazolam is intended exclusively for forensic, pharmaceutical, and advanced pharmacological research. Its primary applications include:

  1. Pharmacological & Neurochemical Research

  • Receptor Binding Assays: Investigation of its high-affinity binding and efficacy at various GABA-A receptor subtypes to understand its enhanced potency compared to alprazolam
  • Metabolic Studies: Research into the Flualprazolam metabolites to map its biotransformation pathway and understand its extended duration of action
  • Comparative Analysis: Studies comparing its effects to other benzodiazepines, addressing questions like ‘Flubromazolam vs Flualprazolam’ and ‘Alprazolam vs Flualprazolam’ in terms of potency, half-life, and side-effect profile
  • Dosage-Response Curves: Establishing precise Flualprazolam dosage parameters for in-vitro and animal model studies

  2. Forensic Toxicology & Public Health

  • Reference Standard: Serves as an essential calibration standard for the accurate identification and quantification of Flualprazolam in seized materials (often disguised as Flualprazolam bars or other pills) and biological specimens
  • Metabolite Identification: Critical for developing targeted LC-MS/MS screens to detect Flualprazolam use in impaired driving and overdose cases
  • Potency & Risk Assessment: Provides data to public health officials on the relative risks of novel psychoactive substances (NPS)

  3. Analytical Method Development

  • Used by pharmaceutical and analytical laboratories to develop and validate highly sensitive methods for detecting this compound and its metabolites

  4. Research Context & Profile
  Understanding the research context is crucial:

  • What is Flualprazolam used for? In a research context, it is used to study the effects of high-potency, long-acting benzodiazepines
  • Flualprazolam half-life is a major subject of study, as its extended duration contributes to accumulation, prolonged effects, and a potentially severe Flualprazolam withdrawal syndrome
  • Research into the Flualprazolam high seeks to understand the neurochemical mechanisms underlying the reported intense sedation and amnesia

  5. CRITICAL SAFETY, LEGAL & HANDLING PROTOCOL
  WARNING: FLUALPRAZOLAM IS AN EXTREMELY POTENT SUBSTANCE. Its high potency and long half-life make it exceptionally dangerous, with a high risk of profound sedation, respiratory depression, amnesia, dependence, and a severe, protracted withdrawal syndrome that can be life-threatening. The legal status of ‘is Flualprazolam legal’ varies by jurisdiction but it is often considered a controlled substance analogue, making its possession illegal without specific authorization.

  Mandatory Safety Protocols for Researchers:

  • Legal Compliance: Researchers must confirm the legal status in their jurisdiction and possess any required licenses for handling controlled substance analogues
  • Environment: Handle in a controlled, secure laboratory environment using appropriate ventilation
  • Personal Protective Equipment (PPE): Wear nitrile gloves, a lab coat, and safety goggles to prevent accidental exposure via inhalation or skin contact
  • Administrative Controls: Maintain meticulous, auditable inventory logs. Store in a double-locked, secure safe
  • Waste Disposal: All waste must be deactivated and disposed of as hazardous chemical waste

  6. Ordering & Packaging Information
  Available for sale only to verified and accredited research institutions:

  • 100 mg (Analytical Reference Standard)
  • 250 mg (Research Quantity)
  • 1 g (Method Development & Extended Study)

  Every Order Includes:

  • Certificate of Analysis (CoA): Detailed report with HPLC purity data and batch-specific information
  • Material Safety Data Sheet (MSDS): Comprehensive safety and handling instructions
  • Secure Packaging: Sealed in a plastic vial within a tamper-evident bag inside anonymous outer packaging